Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In SituE. Shelley Hwang, Doreen M. Agnese, Deborah Collyar et al.|JAMA|2024Cited by 75
Postmastectomy Radiation Therapy: An ASTRO-ASCO-SSO Clinical Practice GuidelineRachel Jimenez, Kathleen C. Horst, Yara Abdou et al.|Journal of Clinical Oncology|2025Cited by 32
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In SituAnn H. Partridge, Kimberly Strickland, Terry Hyslop et al.|JAMA Oncology|2024Cited by 16
POWERPIINC (PreOperative Window of Endocrine TheRapy Provides Information to Increase Compliance) trial: Changes in tumor proliferation index and quality of life with 7 days of preoperative tamoxifenAdam L. Cohen, Leigh Neumayer, Rachel E. Factor et al.|The Breast|2016Cited by 13
Postmastectomy Radiation Therapy: An ASTRO/ASCO/SSO Clinical Practice GuidelineRachel Jimenez, Kathleen C. Horst, Yara Abdou et al.|Practical Radiation Oncology|2025Cited by 6